PeopleBio, Inc. (KOSDAQ:304840)
South Korea · Delayed Price · Currency is KRW 759.00
-41.00 (-5.13%)
At close: Feb 27, 2026
PeopleBio Revenue
PeopleBio had revenue of 1.18B KRW in the quarter ending September 30, 2025, with 23.20% growth. This brings the company's revenue in the last twelve months to 3.36B, down -23.26% year-over-year. In the year 2024, PeopleBio had annual revenue of 3.73B, down -16.20%.
Revenue (ttm)
3.36B
Revenue Growth
-23.26%
P/S Ratio
4.79
Revenue / Employee
72.94M
Employees
46
Market Cap
16.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.73B | -721.35M | -16.20% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | 507.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Cross Medical Science | 111.12B |
| Seoulin Bioscience | 76.74B |
| Dx & Vx | 29.47B |
| Cytogen | 25.09B |
| HLB Panagene | 14.29B |
| Protia | 13.52B |
| 3billion | 9.78B |
| GENINUS | 8.81B |